Ayaka Maeda

Yokohama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Tissue-specific distribution of Coenzyme Q10 in medaka (Oryzias latipes):implications for antioxidant systems in relation to vitamin E, cholesterol, and mitochondrial DNA content.

Tissue-specific distribution of Coenzyme Q10 in medaka (Oryzias latipes):implications for antioxidant systems in relation to vitamin E, cholesterol, and mitochondrial DNA content.

Journal: Free radical research

Published: May 26, 2026

A Case of Glucocorticoid-Resistant VEXAS Syndrome Successfully Treated with Baricitinib.

A Case of Glucocorticoid-Resistant VEXAS Syndrome Successfully Treated with Baricitinib.

Journal: Modern rheumatology case reports

Published: March 25, 2026

VEXAS Syndrome with an Improvement of Chest Shadows Without Immunosuppressive Therapy: A Case Report.

VEXAS Syndrome with an Improvement of Chest Shadows Without Immunosuppressive Therapy: A Case Report.

Journal: Internal medicine (Tokyo, Japan)

Published: March 18, 2026

Human Monocytic Models Reveal Genotype-Dependent Inflammatory Programs in VEXAS Syndrome.

Human Monocytic Models Reveal Genotype-Dependent Inflammatory Programs in VEXAS Syndrome.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: March 03, 2026

Peripheral blood UBA1 variant burden predicts poor outcomes in VEXAS syndrome: a nationwide prospective study.

Peripheral blood UBA1 variant burden predicts poor outcomes in VEXAS syndrome: a nationwide prospective study.

Journal: Annals of the rheumatic diseases

Published: October 27, 2025

Comparative effectiveness and safety of peficitinib and abatacept for rheumatoid arthritis: a multicentre, inverse probability weighting analysis.

Comparative effectiveness and safety of peficitinib and abatacept for rheumatoid arthritis: a multicentre, inverse probability weighting analysis.

Journal: Modern rheumatology

Published: July 28, 2025

High glucocorticoid dependency and limited therapeutic response in Japanese patients with VEXAS syndrome: a multicentre retrospective study.

High glucocorticoid dependency and limited therapeutic response in Japanese patients with VEXAS syndrome: a multicentre retrospective study.

Journal: Modern rheumatology

Published: July 01, 2025

A CASE OF VACUOLES, E1 ENZYME, X-LINKED, AUTOINFLAMMATORY, SOMATIC (VEXAS) SYNDROME PRESENTING WITH DIVERSE PULMONARY LESIONS OVER TIME

A CASE OF VACUOLES, E1 ENZYME, X-LINKED, AUTOINFLAMMATORY, SOMATIC (VEXAS) SYNDROME PRESENTING WITH DIVERSE PULMONARY LESIONS OVER TIME

Journal: Arerugi = [Allergy]

Published: June 11, 2025

Inflammatory myopathy following COVID-19 mRNA vaccination in a patient with VEXAS syndrome.

Inflammatory myopathy following COVID-19 mRNA vaccination in a patient with VEXAS syndrome.

Journal: European journal of dermatology : EJD

Published: November 26, 2024

Distinct features of trisomy 8-associated autoinflammatory disease from Behçet's disease: case series and systematic review.

Distinct features of trisomy 8-associated autoinflammatory disease from Behçet's disease: case series and systematic review.

Journal: Clinical and experimental rheumatology

Published: August 09, 2024

VEXAS syndrome initially presenting as relapsing polychondritis and progressing into neutrophilic dermatosis with systemic symptoms over a 5-year period.

VEXAS syndrome initially presenting as relapsing polychondritis and progressing into neutrophilic dermatosis with systemic symptoms over a 5-year period.

Journal: International journal of dermatology

Published: August 03, 2024

Low remission rates and high incidence of adverse events in a prospective VEXAS syndrome registry.

Low remission rates and high incidence of adverse events in a prospective VEXAS syndrome registry.

Journal: Rheumatology (Oxford, England)

Published: July 11, 2024

Showing 1-12 of 36

Last Updated: 09/26/2026